Mapping and driving the stem cell ecosystem

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The stem cell and regenerative medicine arena has become increasingly complicated in recent years with thousands of people involved. There are as many as a dozen or more main groups of stakeholders, who together may be viewed as one ecosystem that is now rapidly evolving. The nature of the ecosystem and its evolution have major implications for not just those within it, but also for medicine and society at large. Here, I describe this ecosystem and its evolution, as well as the negative impacts within the ecosystem of a constellation of hundreds of unproven for-profit clinics and related businesses. Finally, I propose approaches for how to positively influence and drive the future of the global stem cell ecosystem.

Original languageEnglish (US)
JournalRegenerative Medicine
Volume13
Issue number7
DOIs
StatePublished - Oct 1 2018

Fingerprint

Stem cells
Ecosystems
Ecosystem
Stem Cells
Regenerative Medicine
Medicine
Profitability
Industry

Keywords

  • FDA
  • regenerative medicine
  • stem cell clinical trials
  • stem cell clinics
  • stem cell ecosystem
  • stem cells

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Mapping and driving the stem cell ecosystem. / Knoepfler, Paul S.

In: Regenerative Medicine, Vol. 13, No. 7, 01.10.2018.

Research output: Contribution to journalReview article

@article{51769c66e7444d20863ca57f5d1e1e17,
title = "Mapping and driving the stem cell ecosystem",
abstract = "The stem cell and regenerative medicine arena has become increasingly complicated in recent years with thousands of people involved. There are as many as a dozen or more main groups of stakeholders, who together may be viewed as one ecosystem that is now rapidly evolving. The nature of the ecosystem and its evolution have major implications for not just those within it, but also for medicine and society at large. Here, I describe this ecosystem and its evolution, as well as the negative impacts within the ecosystem of a constellation of hundreds of unproven for-profit clinics and related businesses. Finally, I propose approaches for how to positively influence and drive the future of the global stem cell ecosystem.",
keywords = "FDA, regenerative medicine, stem cell clinical trials, stem cell clinics, stem cell ecosystem, stem cells",
author = "Knoepfler, {Paul S}",
year = "2018",
month = "10",
day = "1",
doi = "10.2217/rme-2018-0056",
language = "English (US)",
volume = "13",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "7",

}

TY - JOUR

T1 - Mapping and driving the stem cell ecosystem

AU - Knoepfler, Paul S

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The stem cell and regenerative medicine arena has become increasingly complicated in recent years with thousands of people involved. There are as many as a dozen or more main groups of stakeholders, who together may be viewed as one ecosystem that is now rapidly evolving. The nature of the ecosystem and its evolution have major implications for not just those within it, but also for medicine and society at large. Here, I describe this ecosystem and its evolution, as well as the negative impacts within the ecosystem of a constellation of hundreds of unproven for-profit clinics and related businesses. Finally, I propose approaches for how to positively influence and drive the future of the global stem cell ecosystem.

AB - The stem cell and regenerative medicine arena has become increasingly complicated in recent years with thousands of people involved. There are as many as a dozen or more main groups of stakeholders, who together may be viewed as one ecosystem that is now rapidly evolving. The nature of the ecosystem and its evolution have major implications for not just those within it, but also for medicine and society at large. Here, I describe this ecosystem and its evolution, as well as the negative impacts within the ecosystem of a constellation of hundreds of unproven for-profit clinics and related businesses. Finally, I propose approaches for how to positively influence and drive the future of the global stem cell ecosystem.

KW - FDA

KW - regenerative medicine

KW - stem cell clinical trials

KW - stem cell clinics

KW - stem cell ecosystem

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=85054984481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054984481&partnerID=8YFLogxK

U2 - 10.2217/rme-2018-0056

DO - 10.2217/rme-2018-0056

M3 - Review article

C2 - 30289055

AN - SCOPUS:85054984481

VL - 13

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 7

ER -